[Effects of synthetic neuropeptides in psycho-organic brain syndrome. Results with ACTH4-10 and ACTH4-9-analog (author's transl)].
The effects of ACTH4-10 (Org O163) and of the ACTH4-9 analog (Org 2766) were tested in 20 male patients suffering from a mild to moderate cerebroorganic impairment. Patients were aged between 51-72 years (mean 60.9). Org 2766 was given in dosages of 0.05 mg, 0.5 mg and 5 mg, Org O163 in a dosage of 30 mg. The investigation was based on a randomized incomplete crossover design. By means of psychological tests the effects of the synthetic neuropeptides on memory, state of well-being, attention, vigilance and psychomotor function were investigated. The statistical analysis of the results did not reveal any effects of both substances on the functions tested. These results are in agreement with those of other studies in man using similar methods and acute administration of ACTH4-10 and/or Org 2766. In such studies only effects of reactive inhibition of attention and motivation could be demonstrated consistently.
D000324:Adrenocorticotropic Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000368:Aged; D002986:Clinical Trials as Topic; D006801:Humans; D008297:Male; D008568:Memory / Q000187:drug effects; D008875:Middle Aged; D009048:Motor Skills; D019965:Neurocognitive Disorders / Q000188:drug therapy*; D010446:Peptide Fragments / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D011930:Reaction Time / Q000187:drug effects
D010446:Peptide Fragments; C013765:Org 2766; D000324:Adrenocorticotropic Hormone; C011394:ACTH (4-10)
Wirkungen synthetischer Neuropeptide auf die hirnorganische Leistungsinsuffizienz. Ergebnisse der Anwendung von ACTH4-10 und des ACTH4-9-Analogon.